Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/31/2013US20130288956 Combined pharmaceutical composition as antifungal agent
10/31/2013US20130288954 Use of chelating agent and peptide antimicrobial compounds
10/31/2013US20130288952 Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use
10/31/2013US20130288950 Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress
10/31/2013US20130288949 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
10/31/2013US20130287852 Compositions for nasal administration of pharmaceuticals
10/31/2013US20130287839 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
10/31/2013US20130287817 Flowable implant with crosslinkable surface membrane
10/31/2013US20130287803 Novel uses of vegfxxxb
10/31/2013US20130287800 Immunization with amyloid-beta oligomers
10/31/2013US20130287785 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
10/31/2013US20130287760 Treatment for dupuytren's disease
10/31/2013US20130287759 Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
10/31/2013US20130287758 Injectable Amino-Acid Composition
10/31/2013US20130287757 Composition for the regeneration of atrophic tissues
10/31/2013US20130287754 ANTIMICROBIAL ANGIOGENIN COMPLEXES (ANGex) AND USES THEREOF
10/31/2013US20130287753 Compositions and Methods for Cartilage Repair
10/31/2013US20130287740 Compositions for preparing a coffee beverage comprising hydrolysed chlorogenic acid
10/31/2013US20130287739 Serca2 therapeutic compositions and methods of use
10/31/2013US20130287738 Disease-associated protein
10/31/2013US20130287734 Liquid formulations of long acting interferon alpha conjugate
10/31/2013US20130287732 Neuroprotection in Demyelinating Diseases
10/31/2013US20130287728 Compositions and Methods for Treating Progressive Myocardial Injury Due to A Vascular Insufficiency
10/31/2013US20130287726 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
10/31/2013US20130287715 Use of natural active substances in cosmetic or therapeutic compositions
10/31/2013US20130287693 NOGO Receptor Binding Protein
10/31/2013US20130287681 Somatostatin receptor-based cancer therapy
10/30/2013EP2657338A1 HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
10/30/2013EP2657252A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
10/30/2013EP2656855A2 Pharmaceutical preparation for the treatment of depressive pathologies, comprising a protein with a high tryptophan-LNAAs (Large Neutral Amino Acids) ratio
10/30/2013EP2656854A1 Uses of aromatic-cationic peptide
10/30/2013EP2656853A1 Method for treating acute cerebral and spinal blood flow disorders of an ischaemic or haemorrhagic nature
10/30/2013EP2656836A1 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
10/30/2013EP2655610A2 Antimicrobial agents
10/30/2013EP2655607A2 Methods and compositions for producing active vitamin k-dependent proteins
10/30/2013EP2655411A1 Fibronectin based scaffold domain proteins that bind il-23
10/30/2013EP2655410A2 Anti-inflammatory proteins and methods of preparation and use thereof
10/30/2013EP2655409A1 Superagonists and antagonists of interleukin-2
10/30/2013EP2655408A1 Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
10/30/2013EP2655401A2 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
10/30/2013EP2655400A1 Factor h binding peptides and uses thereof
10/30/2013EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/30/2013EP2655353A1 Derivatives of glyco-cf2-serine and glyco-cf2-threonine
10/30/2013EP2654897A1 Method for increasing embryo implantation rate in mother's uterus in mammals, use of an effective amount of beta - galactoside - binding lectin or derivatives thereof, beta - galactoside - binding lectin or derivatives and product.
10/30/2013EP2654800A1 Therapeutic strategies to treat cns pathology in mucopolysaccharidoses
10/30/2013EP2654791A1 Methods for treating systemic lupus erythematosus using hiv protease inhibitors
10/30/2013EP2654777A2 Methods and compositions suitable for managing blood glucose in animals
10/30/2013EP2654776A1 Use of pegylated recombinant human arginase for treatment of leukemia
10/30/2013EP2654775A1 uPAR-ANTAGONISTS AND USES THEREOF
10/30/2013EP2654774A2 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
10/30/2013EP2654773A2 Glucagon analogs exhibiting gip receptor activity
10/30/2013EP2654772A2 Cyclic crf antagonist peptides
10/30/2013EP2654771A1 Tear substitutes
10/30/2013EP2654770A1 Pharmaceutical compositions of tenecteplase
10/30/2013EP2654769A2 Antitumor peptide derived from a complementarity determining region of a humanized monoclonal antibody to napi2b transporter
10/30/2013EP2654768A1 Peptides for treating cancer
10/30/2013EP2654767A2 Glp-1 receptor agonists for islet cell transplantation
10/30/2013EP2654760A1 Viral inactivated platelet extract, use and preparation thereof
10/30/2013EP2654758A1 A composition comprising at least two compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
10/30/2013EP2332582B1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
10/30/2013CN1264307B Method of enhancing function of upper gastrointestinal tract
10/30/2013CN103380143A Fibronectin based scaffold domain proteins that bind IL-23
10/30/2013CN103380108A Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups
10/30/2013CN103379915A HSA-related compositions and methods of use
10/30/2013CN103379914A Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mRNA
10/30/2013CN103379913A Peptides for treating cancer
10/30/2013CN103379912A N-carboxyalkyl auristatins and the use thereof
10/30/2013CN103379911A PGC-1[alpha]-modulating peptides
10/30/2013CN103379909A Novel bacterium and extracts of said bacterium and the use of same in therapy
10/30/2013CN103374577A Sheep ISG (immune serum globulin) 15 recombinant protein as well as coding gene and application thereof
10/30/2013CN103374557A Mannose glycosylated lysozyme and application thereof
10/30/2013CN103374552A PHF 8 (Plant Homedomain Finger Protein 8) protein fragment as well as prokaryotic expression and purification method and antibody thereof
10/30/2013CN103374066A Alpha B-O-conotoxin and medicine composition and application thereof
10/30/2013CN103374058A Solid-phase synthesis process of angiotensinamide as well as intermediate and application thereof
10/30/2013CN103374057A New compound with inhibiting activity to glycine transporters
10/30/2013CN103374056A 1-Acetyl-beta-carboline-3-formyl amino-acid benzyl ester, and synthesis and application thereof
10/30/2013CN103372202A Lactoprotein/fatty acid-containing composition, and preparation method and application thereof
10/30/2013CN103372201A Hard capsule formula and production method thereof
10/30/2013CN103372200A Application of oxetanocin in preparation of antiviral medicament
10/30/2013CN103372199A Novel brain targeting preparation for preventing and treating neurodegenerative disease
10/30/2013CN103372198A Polypeptide suppressant for suppressing virus
10/30/2013CN103372197A Composition for preventing and treating female climacteric syndrome and preparation method thereof
10/30/2013CN103371973A Externally coated nanometer multiple emulsion for promoting oral absorption of insulin
10/30/2013CN103371970A Oxytocin injection and preparation process thereof
10/30/2013CN102920999B Application of Chinese yarn glycoprotein in preparation of medicament for treating nephritis and renal hypertension
10/30/2013CN102836414B External Chinese medicinal oil for treating herpes zoster, burn and scald and bedsore
10/30/2013CN102552216B Snake poison pain-relieving polypeptide nanocapsule and preparation method and application thereof
10/30/2013CN102512655B L-carnitine composition, L-carnitine preparation and preparation method and application thereof
10/30/2013CN102397528B Compound propolis composition for treating chicken infectious anemia and preparation method thereof
10/30/2013CN102397526B Application of Jingzhaotoxin-V to preparation of medicine for resisting cognitive, learning and memory dysfunction
10/30/2013CN102188693B Proteoglycan complex
10/30/2013CN102180971B Recombinant beta-amyloid peptide B cell epitope polypeptide chimeric antigen and preparation method and application thereof
10/30/2013CN102159223B Treating or preventing rotavirus infection
10/30/2013CN101809038B Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/30/2013CN101611050B Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
10/30/2013CN101550185B Tumor-related gene or protein and application thereof
10/30/2013CN101506364B SDF-I binding nucleic acids
10/30/2013CN101495135B Treatment of pain by use of single chain polypeptide fusion protein
10/30/2013CN101460189B Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units
10/30/2013CN101044242B Tumor specific antibody
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 3163